🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
116 results for “ehr”
MedicineActive substanceLicence holderStatus
Micardis 80 mg tablets
EU/1/98/090/005-008
Telmisartan Boehringer Ingelheim International GmbH
MicardisPlus 40 mg/12.5 mg tablets
EU/1/02/213/001-005
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
MicardisPlus 80 mg/12.5 mg tablets
EU/1/02/213/006-010
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
MicardisPlus 80 mg/25 mg tablets
EU/1/02/213/17-23
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
MIRAPEXIN 0.088 mg tablets
EU/1/97/051/001-002
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.18 mg tablets
EU/1/97/051/003-004
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.26 mg prolonged-release tablets
EU/1/97/051/13-15
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.35 mg tablets
EU/1/97/051/011-012
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.52 mg prolonged-release tablets
EU/1/97/051/16-18
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.7 mg tablets
EU/1/97/051/005-006
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 1.05 mg prolonged-release tablets
EU/1/97/051/19-21
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 1.57 mg prolonged-release tablets
EU/1/97/051/028-30
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 2.1 mg prolonged-release tablets
EU/1/97/051/22-24
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 2.62 mg prolonged-release tablets
EU/1/97/051/031-33
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 3.15 mg prolonged-release tablets
EU/1/97/051/25-27
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
Ofev 100 mg Soft capsule
EU/1/14/979/001-002
Nintedanib Boehringer Ingelheim International GmbH
Ofev 150 mg Soft capsule
EU/1/14/979/003-004
Nintedanib Boehringer Ingelheim International GmbH
Ofev 25mg Soft capsule
EU/1/14/979/009-012
Nintedanib esylate Boehringer Ingelheim International GmbH
Pradaxa 110 mg coated granules
EU/1/08/442/0029
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 110 mg hard capsules
EU/1/08/442/5-8
Dabigatran etexilate Boehringer Ingelheim International GmbH
Pradaxa 150 mg coated granules
EU/1/08/442/030
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 150 mg hard capsules
EU/1/08/442/009-013
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 20 mg coated granules
EU/1/08/442/025
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 30 mg coated granules
EU/1/08/442/0026
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 40 mg coated granules
EU/1/08/442/0027
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 50 mg coated granules
EU/1/08/442/028
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 75 mg hard capsules
EU/1/08/442/1-4
Dabigatran etexilate Boehringer Ingelheim International GmbH
Praxbind 2.5 g/50 mL solution for injection/infusion
EU/1/15/1056/001
Idarucizumab Boehringer Ingelheim International GmbH
Privigen 100 mg/ml solution for infusion
EU/1/08/446/1-3
Human normal immunoglobulin CSL Behring GmbH
Respreeza 1,000 mg powder and solvent for solution for infusion.
EU/1/15/1006/001
Human alpha1-proteinase inhibitor CSL Behring GmbH
Rhophylac 300 micrograms/2 ml, solution for injection in pre-filled syringe
PA0800/006/002
Human anti-D immunoglobulin CSL Behring GmbH Marketed
Riastap 1 g Powder for Solution for Injection/Infusion
PA0800/007/001
Human fibrinogen CSL Behring GmbH Not marketed
SIFROL 0.088 mg tablets
EU/1/97/050/001-002
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 0.18 mg tablets
EU/1/97/050/003-004
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 0.26 mg prolonged-release tablets
EU/1/97/050/013-015
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 0.35 mg tablets
EU/1/97/050/011-012
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 0.52 mg prolonged-release tablets
EU/1/97/050/016-018
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 0.7 mg tablets
EU/1/97/050/005-006
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 1.05 mg prolonged-release tablets
EU/1/97/050/19-21
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 1.57 mg prolonged-release tablets
EU/1/97/050/028-30
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 2.1 mg prolonged-release tablets
EU/1/97/050/22-24
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 2.62 mg prolonged-release tablets
EU/1/97/050/031-33
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
SIFROL 3.15 mg prolonged-release tablets
EU/1/97/050/25-27
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution
PA0775/009/001
Tiotropium, Olodaterol Boehringer Ingelheim International GmbH Marketed
SPIRIVA 18 microgram, inhalation powder, hard capsule
PA0775/002/001
Tiotropium bromide Boehringer Ingelheim International GmbH Marketed
Spiriva Respimat 2.5 microgram inhalation solution
PA0775/002/002
Tiotropium bromide Boehringer Ingelheim International GmbH Marketed
Striverdi Respimat 2.5 microgram inhalation solution
PA0775/006/001
Olodaterol Boehringer Ingelheim International GmbH Marketed
Synjardy 12.5 mg/1,000 mg film-coated tablets
EU/1/15/1003/028-036
Empagliflozin, Metformin Hydrochloride Boehringer Ingelheim International GmbH
Synjardy 12.5 mg/850 mg film-coated tablets
EU/1/15/1003/019-027
Empagliflozin, Metformin Hydrochloride Boehringer Ingelheim International GmbH
Synjardy 5 mg/1,000 mg film-coated tablets
EU/1/15/1003/010-018
Empagliflozin, Metformin Hydrochloride Boehringer Ingelheim International GmbH
1 2 3
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 10 September 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.